Market Overview

Barclays Expects IBM's Cost Cuts To More Than Offset Weak Revenue

Barclays Expects IBM's Cost Cuts To More Than Offset Weak Revenue
Related IBM
The World's Most Valuable Brands In 2017: Apple, Google, Coca-Cola And More
Apple's September 12 Event: New Products And The Tech Sector's Push Into Healthcare

International Business Machines Corp. (NYSE: IBM) has been aggressively cutting costs to counter the adverse impact of cloud disruption, Barclays’ Mark Moskowitz said in a report. He maintained an Underweight rating on the company, while raising the price target from $125 to $140.

Since a significant part of IBM’s cloud-based revenue can have low margins in the first couple of years of deployment, the company has been focusing on reducing costs aggressively, analyst Mark Moskowitz noted.

“Teeter Totter” Effect

While IBM continues to struggle with revenue weakness, it may have been able to offset this with aggressive cost cuts. Moskowitz lowered the revenue estimates for the June quarter and 2016 from $19.6Bn to $19.5Bn and from $78.3Bn to $77.8Bn, respectively. At the same time, the operating margin estimates have been raised from 17.5 percent to 18.4 percent and from 18.5 percent to 18.9 percent, respectively.

The EPS estimates for FY1 and FY2 have been raised from $13.32 to $13.48 and from $13.51 to $13.87, respectively.

Related Link: AT&T, IBM Align To Bring Improved IoT Capabilities To Developers On IBM Cloud

Middleware Still A Challenge

“Despite growth in IBM's strategic imperatives, middleware continues to be the company's profit engine,” the analyst wrote. He expects middleware to continue to be at risk, with an estimated 30-35 percent of middleware revenue being related to SMB customers, who are more likely to move to cloud over time.

While IBM’s margins may be boosted by cost cuts, this does not seem sufficient to “become more constructive on the stock,” Moskowitz commented.

Did you like this article? Could it have been improved? Please email to let us know!

Latest Ratings for IBM

Aug 2017WedbushInitiates Coverage OnNeutral
Jul 2017ArgusMaintainsBuy
Jul 2017Standpoint ResearchUpgradesHoldBuy

View More Analyst Ratings for IBM
View the Latest Analyst Ratings

Posted-In: Barclays Mark MoskowitzAnalyst Color Short Ideas Price Target Reiteration Analyst Ratings Trading Ideas Best of Benzinga


Related Articles (IBM)

View Comments and Join the Discussion!